Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shion A Lim

Showing results (11-20 of 25) with videos related to

Pageof 3
Sort By:
Msphere|September 17, 2020
Competitive SARS-CoV-2 Serology Reveals Most Antibodies Targeting the Spike Receptor-Binding Domain Compete for ACE2 BindingJames R Byrnes, Xin X Zhou, Irene Lui, et al.
Mabs|March 5, 2021
Bispecific VH/Fab antibodies targeting neutralizing and non-neutralizing Spike epitopes demonstrate enhanced potency against SARS-CoV-2Shion A Lim, Josef A Gramespacher, Katarina Pance, et al.
The Journal of Clinical Investigation|February 15, 2022
Targeting a proteolytic neoepitope on CUB domain containing protein 1 (CDCP1) for RAS-driven cancersShion A Lim, Jie Zhou, Alexander J Martinko, et al.
Biorxiv : the Preprint Server for Biology|August 21, 2020
Bi-paratopic and multivalent human VH domains neutralize SARS-CoV-2 by targeting distinct epitopes within the ACE2 binding interface of SpikeColton J Bracken, Shion A Lim, Paige Solomon, et al.
Nature Chemical Biology|October 21, 2020
Bi-paratopic and multivalent VH domains block ACE2 binding and neutralize SARS-CoV-2Colton J Bracken, Shion A Lim, Paige Solomon, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 29, 2020
Theranostic Targeting of CUB Domain Containing Protein 1 (CDCP1) in Pancreatic CancerAnna Moroz, Yung-Hua Wang, Jeremy M Sharib, et al.
Medrxiv : the Preprint Server for Health Sciences|August 26, 2020
Engineering luminescent biosensors for point-of-care SARS-CoV-2 antibody detectionSusanna K Elledge, Xin X Zhou, James R Byrnes, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 23, 2020
Engineered ACE2 receptor traps potently neutralize SARS-CoV-2Anum Glasgow, Jeff Glasgow, Daniel Limonta, et al.
Biorxiv : the Preprint Server for Biology|August 9, 2020
Engineered ACE2 receptor traps potently neutralize SARS-CoV-2Anum Glasgow, Jeff Glasgow, Daniel Limonta, et al.
Nature Biotechnology|March 26, 2021
Engineering luminescent biosensors for point-of-care SARS-CoV-2 antibody detectionSusanna K Elledge, Xin X Zhou, James R Byrnes, et al.
Pageof 3

Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
Msphere|September 17, 2020
Competitive SARS-CoV-2 Serology Reveals Most Antibodies Targeting the Spike Receptor-Binding Domain Compete for ACE2 BindingJames R Byrnes, Xin X Zhou, Irene Lui, et al.
Mabs|March 5, 2021
Bispecific VH/Fab antibodies targeting neutralizing and non-neutralizing Spike epitopes demonstrate enhanced potency against SARS-CoV-2Shion A Lim, Josef A Gramespacher, Katarina Pance, et al.
The Journal of Clinical Investigation|February 15, 2022
Targeting a proteolytic neoepitope on CUB domain containing protein 1 (CDCP1) for RAS-driven cancersShion A Lim, Jie Zhou, Alexander J Martinko, et al.
Biorxiv : the Preprint Server for Biology|August 21, 2020
Bi-paratopic and multivalent human VH domains neutralize SARS-CoV-2 by targeting distinct epitopes within the ACE2 binding interface of SpikeColton J Bracken, Shion A Lim, Paige Solomon, et al.
Nature Chemical Biology|October 21, 2020
Bi-paratopic and multivalent VH domains block ACE2 binding and neutralize SARS-CoV-2Colton J Bracken, Shion A Lim, Paige Solomon, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 29, 2020
Theranostic Targeting of CUB Domain Containing Protein 1 (CDCP1) in Pancreatic CancerAnna Moroz, Yung-Hua Wang, Jeremy M Sharib, et al.
Medrxiv : the Preprint Server for Health Sciences|August 26, 2020
Engineering luminescent biosensors for point-of-care SARS-CoV-2 antibody detectionSusanna K Elledge, Xin X Zhou, James R Byrnes, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 23, 2020
Engineered ACE2 receptor traps potently neutralize SARS-CoV-2Anum Glasgow, Jeff Glasgow, Daniel Limonta, et al.
Biorxiv : the Preprint Server for Biology|August 9, 2020
Engineered ACE2 receptor traps potently neutralize SARS-CoV-2Anum Glasgow, Jeff Glasgow, Daniel Limonta, et al.
Nature Biotechnology|March 26, 2021
Engineering luminescent biosensors for point-of-care SARS-CoV-2 antibody detectionSusanna K Elledge, Xin X Zhou, James R Byrnes, et al.
Pageof 3